[引用][C] Formulasi Obat Kumur Ekstrak Drymoglossum piloselloides L. sebagai Antibakteri Streptococcus sp.

M Sari, L Leny, A Cahyani - Majalah Farmasetika, 2023

[HTML][HTML] Waning anti-SARS-CoV-2 receptor-binding domain total antibody in CoronaVac-vaccinated individuals in Indonesia

H Harapan, HA Royan, II Tyas, A Nadira, IF Abdi… - …, 2022 - ncbi.nlm.nih.gov
Background: The decrease of immunity acquired from COVID-19 vaccines is a potential
cause of breakthrough infection. Understanding the dynamics of immune responses of …

[HTML][HTML] 4'-fluorouridine as a potential COVID-19 oral drug?: a review

AH Abas, TE Tallei, F Fatimawali, I Celik… - …, 2023 - f1000research.com
Background: Although vaccination is underway, antiviral drugs against coronavirus disease
2019 (COVID-19) are lacking. Remdesivir, a nucleoside analog that works by inhibiting the …

[HTML][HTML] Association Between Lymphocyte Level and Severity of Coronavirus Disease 2019 Patients: A Cross-sectional Study in Indonesia

B Buchari, H Andayani, NA Putri - Open Access Macedonian Journal of …, 2022 - oamjms.eu
BACKGROUND: Coronavirus disease 2019 (COVID-19) pandemic has caused significant
health problems globally. COVID-19 should be considered a systemic disease since it …

Prevention is better than healing. Clinical and economic implications of oral antiviral agents in COVID-19: a prospective study

F Pietrantonio, F Rosiello, M Ruggeri… - Italian Journal of …, 2024 - italjmed.org
COVID-19 represents a threat for frailty patients. This study compares molnupiravir and
nirmatrelvir for fragile COVID-19 patients' efficacy, safety, and cost. An observational …

Coffee by-products as the source of antioxidants: a systematic review

L Wahyu, H Kartini, LM Yulianto, S Sofia - F1000Research, 2022 - search.proquest.com
Background: Solid waste from coffee depulping process threatens the organism in
environment as it produces organic pollutants. Evidence suggested that coffee by-product …

[PDF][PDF] 4'-fluorouridine as a potential COVID-19 oral drug?: a review [version 2; peer review: 1 approved with reservations

AH Abas, TE Tallei, F Fatimawali, I Celik… - 2023 - researchgate.net
The available antiviral drugs against coronavirus disease 2019 (COVID-19) are limited. Oral
drugs that can be prescribed to non-hospitalized patients are required. The 4′-fluoruridine …

[PDF][PDF] Waning anti-SARS-CoV-2 neutralizing antibody in CoronaVac-vaccinated individuals in Indonesia [version 1; peer review

H Harapan, HA Royan, II Tyas, A Nadira, IF Abdi… - pdfs.semanticscholar.org
Background: The decrease of immunity acquired from COVID-19 vaccines is a potential
cause of breakthrough infection. Understanding the dynamics of immune responses of …

[PDF][PDF] 4'-fluorouridine and its derivatives as potential COVID-19 ora l drugs: a review [version 1; peer review: awaiting peer review]

AH Abas, TE Tallei, F Fatimawali, I Celik… - researchgate.net
Background: Although vaccination is underway, antiviral drugs against coronavirus disease
2019 (COVID-19) are lacking. Remdesivir, a nucleoside analog that works by inhibiting the …

[引用][C] Recent update on long COVID syndrome: Immunopathogenesis and clinical consequences

G Soegiarto, KM Djajapranata - Bali Medical Journal, 2024